Table 3.
Middle-Aged | Older | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Male | Female | Male | Female | ||||||||
Antecedent | Consequent | Lift | Antecedent | Consequent | Lift | Antecedent | Consequent | Lift | Antecedent | Consequent | Lift |
CBD + OARA + HT | IHD | 3.487 | CBD + OARA + COPD | IHD | 3.237 | IHD + OARA + Glaucoma | Cataract | 2.450 | Glaucoma | Cataract | 2.952 |
CBD + OARA | IHD | 3.321 | CBD + COPD | IHD | 3.169 | IHD + Glaucoma | Cataract | 2.419 | OARA + PUD + CKD | COPD | 2.008 |
OARA + HT + PUD | IHD | 3.020 | CBD + OARA + HT | IHD | 3.134 | HT + Glaucoma | Cataract | 2.417 | IHD + DD + OARA + HT | IHD | 2.006 |
COPD + OARA + HT | IHD | 2.981 | CBD + OARA | IHD | 2.992 | OARA + Glaucoma | Cataract | 2.382 | IHD + COPD + DD | IHD | 1.997 |
DM + OARA + HT | IHD | 2.945 | CBD + HT | IHD | 2.874 | Glaucoma | Cataract | 2.311 | IHD + CKD + PUD | COPD | 1.992 |
COPD + DM | IHD | 2.781 | COPD + DM + OARA + HT | IHD | 2.821 | CBD + CKD + HT | DM | 2.062 | CKD + PUD + HT | COPD | 1.961 |
COPD + HT | IHD | 2.692 | COPD + PUD + OARA + HT | IHD | 2.764 | IHD + CKD + HT | DM | 1.953 | IHD + DM + OARA + PUD + HT | IHD | 1.957 |
PUD + HT | IHD | 2.637 | COPD + DM + HT | IHD | 2.736 | CBD + IHD + CKD | DM | 1.946 | CBD + IHD + CKD + OARA + HT | COPD | 1.956 |
COPD + PUD | OARA | 2.623 | COPD + PUD + HT | IHD | 2.711 | IHD + CKD + OARA + HT | DM | 1.937 | IHD + DD + HT | IHD | 1.952 |
CBD + HT | IHD | 2.593 | CBD | IHD | 2.692 | CBD + CKD | DM | 1.933 | CKD + OARA + Cataract | COPD | 1.945 |
Abbreviations: CBD, cerebrovascular disease; IHD, ischaemic heart disease; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; DD, depressive disorders; CKD, chronic kidney disease; OARA, osteoarthritis and rheumatoid arthritis; PUD, peptic ulcer disease; HT, hypertension.